Skip to content

13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-13, with 10 holding rows worth $130,066,695.

Accession
0001012975-24-000321
Filed
2024-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 10 entries on the cover page, a total value of $130,066,695 stated on the cover page (in dollars after the unit check, H1), rows summing to $130,066,695 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VAXCYTE INC COM92243G108Stock793,036$59,882,148dollars as filed
INOZYME PHARMA INC45790W108COM4,494,851$20,047,035dollars as filed
OCULIS HOLDING AGH5870P102CMN1,595,918$19,071,220dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM2,041,108$18,982,304dollars as filed
EXSCIENTIA PLC30223G102ADS770,500$3,929,550dollars as filed
RALLYBIO CORP75120L100COM2,404,644$3,222,223dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM560,595$2,242,380dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM1,891,467$1,418,600dollars as filed
IO BIOTECH INC449778109COM864,197$1,011,110dollars as filed
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock743,215$260,125dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-24-000321this filing2024-08-13acceptance time not in the bulk data set